Bioline announces worldwide release of MyTaq Extract-PCR Kit

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the MyTaq^TM Extract-PCR Kit.

“With the MyTaqTM Extract-PCR Kit; researchers can now quickly achieve the purity and yield necessary for high-performance PCR and real time PCR experiments from solid tissues, such as mouse tail or mouse ear. This makes MyTaqTM extract the perfect addition to our widely used PCR reagents.”

Powered by the high performance MyTaq^TM DNA Polymerase, the MyTaq^TM Extract-PCR Kit offers a quick and easy alternative for the extraction and amplification of DNA from a variety of mammalian tissue types. Researchers using the MyTaq^TM Extract-PCR Kit can replace complicated and time consuming extraction methods with a simple 15 minute, single tube, protocol; making it perfect for high throughput applications, such as mouse genotyping and sequencing.

Marco Calzavara, President of Bioline commented, "With the MyTaq^TM Extract-PCR Kit; researchers can now quickly achieve the purity and yield necessary for high-performance PCR and real time PCR experiments from solid tissues, such as mouse tail or mouse ear. This makes MyTaq^TM extract the perfect addition to our widely used PCR reagents."

Richard L. Eberly, President of Meridian Life Science, Inc., stated, "We are delighted to release the MyTaq^TM Extract-PCR Kit, another product in the rapidly expanding portfolio of highly specialized molecular biology reagents from Bioline. We are committed to our life science customers and to bringing innovation and quality products; such as the family of MyTaq™ products to the research laboratory, clinical diagnostic laboratories, and biotechnology companies."